August 23, 2017

AbbVie’s Mavyret: The Hepatitis C Treatment We’ve Been Waiting For?

Mavyret is the newly approved hepatitis C medications. The Food and Drug Administration (FDA) recently approved AbbVie’s Mavyret, the newest treatment for chronic hepatitis C virus infection for […]
August 22, 2017

FDA approves new drug to treat hepatitis C

There is a new medication for treating hepatitis C. Last week, the Food and Drug Administration approved the use of a new drug for treating all […]
August 21, 2017

FDA clears hepatitis C drug Mavyret

Mavyret, from AbbVie, joins the market to treat hepatitis C. The Food and Drug Administration has approved a new drug to treat adults with chronic hepatitis […]
August 18, 2017

FDA OKs new drug to treat all forms of hepatitis C

There are now seven FDA-approved hepatitis C medications on the market. U.S. regulators have approved the first drug to treat all forms of hepatitis C in as little […]
August 17, 2017

FDA OKs AbbVie’s Mavyret for All Hepatitis C Genotypes

There’s a newly approved hepatitis C medication. The Food and Drug Administration (FDA) has approved AbbVie’s once-daily Mavyret to treat all six major genotypes of hepatitis C virus […]
August 16, 2017

Hepatitis C is testing us. We will not fail.

Early detection of hepatitis C is essential. You may know hepatitis C (HCV) is a serious disease that can damage the liver and lead to liver cancer. […]
August 15, 2017

Opinion: Hepatitis C, a silent killer that deserves more attention

Hepatitis C deserves more attention than it receives. Hepatitis C is a silent killer. People can have it for decades without any symptoms. Yet, this virus […]
August 14, 2017

Hepatitis C Treatment

Today’s hepatitis C treatments no longer require interferon. The paradigm of hepatitis C virus (HCV) treatment has changed drastically in the past 20 years. In the early 1990s, […]